111 Capital’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
111 Capital's HALO Position: Q2 2026 in Review
111 Capital opened a new position in Halozyme (HALO) in Q2 2026: 4,826 shares worth $378K. The stake represents 0.06% of the portfolio and ranks #285 among its holdings. This is a return to the name: 111 Capital previously reported a position in HALO as recently as Q3 2025.
111 Capital first reported a position in HALO in Q2 2025 and has held it in 3 quarters since. The position peaked at $689K in Q2 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- 111 Capital held 4,826 shares of Halozyme worth $378K as of Q2 2026.
- Halozyme was a new 111 Capital position in Q2 2026.
- Halozyme made up 0.06% of 111 Capital's portfolio in Q2 2026, its #285 holding.
- 111 Capital first reported a position in Halozyme in Q2 2025 and has held it in 3 quarters since.
- 111 Capital's Halozyme position peaked at $689K in Q2 2025.
- 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.